Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Microbot Medical Inc. (MBOT)

1.4800 0.0000 (0.00%)
As of 11:08:12 AM EDT. Market Open.
Trade MBOT on Coinbase
Chart Range Bar
Loading chart for MBOT
  • Previous Close 1.4800
  • Open 1.4900
  • Bid 1.0700 x 200
  • Ask 1.9200 x 200
  • Day's Range 1.4600 - 1.4999
  • 52 Week Range 1.4400 - 4.6700
  • Volume 204,336
  • Avg. Volume 780,219
  • Market Cap (intraday) 99.404M
  • Beta (5Y Monthly) 1.05
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2500
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 6.67

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

microbotmedical.com

43

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 8/31/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MBOT
26.00%
S&P 500 (^GSPC)
12.11%

1-Year Return

MBOT
61.15%
S&P 500 (^GSPC)
18.80%

3-Year Return

MBOT
32.42%
S&P 500 (^GSPC)
70.25%

5-Year Return

MBOT
80.53%
S&P 500 (^GSPC)
69.69%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 105k
Earnings -3.67M
Profit Margin -3,496.19%

Q3

FY25

Q4

FY25

Q1

FY26

-3M
-2M
-1M
0
-3000.0%
-2000.0%
-1000.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

4.00
6.67 Average
1.4800 Current
12.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/14/2026
Analyst B. Riley Securities
Rating Action Reiterates
Rating Buy
Price Action Lowers
Price Target 5 -> 4

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    100.75M

  • Enterprise Value

    34.26M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    270.82

  • Price/Book (mrq)

    1.46

  • Enterprise Value/Revenue

    99.01

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -21.72%

  • Return on Equity (ttm)

    -32.91%

  • Revenue (ttm)

    346k

  • Net Income Avi to Common (ttm)

    -16.34M

  • Diluted EPS (ttm)

    -0.2500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    67.37M

  • Total Debt/Equity (mrq)

    1.27%

  • Levered Free Cash Flow (ttm)

    -14.24M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

1.4800 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: